{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:09:16Z","timestamp":1792069756729,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1038\/s41409-019-0641-y","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T15:03:08Z","timestamp":1566399788000},"page":"93-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Features of Toxoplasma gondii reactivation after allogeneic hematopoietic stem-cell transplantation in a high seroprevalence setting"],"prefix":"10.1038","volume":"55","author":[{"given":"Olivier","family":"Paccoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Guitard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Labopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Surgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3474-0002","authenticated-orcid":false,"given":"Florent","family":"Malard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5201-1786","authenticated-orcid":false,"given":"Giorgia","family":"Battipaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Dul\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Hennequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eolia","family":"Brissot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,21]]},"reference":[{"key":"641_CR1","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1086\/317471","volume":"31","author":"R Martino","year":"2000","unstructured":"Martino R, Maertens J, Bretagne S, Rovira M, Deconinck E, Ullmann AJ. et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis. 2000;31:1188\u201395.","journal-title":"Clin Infect Dis"},{"key":"641_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/QCO.0000000000000169","volume":"28","author":"K Gajurel","year":"2015","unstructured":"Gajurel K, Dhakal R, Montoya JG. Toxoplasma prophylaxis in haematopoietic cell transplant recipients: a review of the literature and recommendations. Curr Opin Infect Dis. 2015;28:283\u201392.","journal-title":"Curr Opin Infect Dis"},{"key":"641_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1086\/426447","volume":"40","author":"R Martino","year":"2005","unstructured":"Martino R, Bretagne S, Einsele H, Maertens J, Ullmann AJ, Parody R. et al. Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis. 2005;40:67\u201378.","journal-title":"Clin Infect Dis"},{"key":"641_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1086\/651266","volume":"50","author":"S Meers","year":"2010","unstructured":"Meers S, Lagrou K, Theunissen K, Dierickx D, Delforge M, Devos T, et al. Myeloablative conditioning predisposes patients for Toxoplasma gondii reactivation after allogeneic stem cell transplantation. Clin Infect Dis. 2010;50:1127\u201334.","journal-title":"Clin Infect Dis"},{"key":"641_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.3201\/eid2408.180045","volume":"24","author":"F Robert-Gangneux","year":"2018","unstructured":"Robert-Gangneux F, Meroni V, Dupont D, Botterel F, Garcia JMA, Brenier-Pinchart M-P, et al. Toxoplasmosis in transplant recipients, Europe, 2010\u20132014. Emerg Infect Dis 2018;24:1497\u2013504.","journal-title":"Emerg Infect Dis"},{"key":"641_CR6","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1469-0691.2008.02091.x","volume":"14","author":"F Derouin","year":"2008","unstructured":"Derouin F, Pelloux H. ESCMID Study Group on Clinical Parasitology. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008;14:1089\u2013101.","journal-title":"Clin Microbiol Infect"},{"key":"641_CR7","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/bmt.2009.254","volume":"44","author":"Center for International Blood and Marrow Transplant Research (CIBMTR), National Marrow Donor Program (NMDP), European Blood and Marrow Transplant Group (EBMT), American Society of Blood and Marrow Transplantation (ASBMT), Canadian Blood and Marrow Transplant Group (CBMTG), Infectious Disease Society of America (IDSA)","year":"2009","unstructured":"Center for International Blood and Marrow Transplant Research (CIBMTR), National Marrow Donor Program (NMDP), European Blood and Marrow Transplant Group (EBMT), American Society of Blood and Marrow Transplantation (ASBMT), Canadian Blood and Marrow Transplant Group (CBMTG), Infectious Disease Society of America (IDSA) et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant. 2009;44:453\u2013558.","journal-title":"Bone Marrow Transplant"},{"key":"641_CR8","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/infdis\/171.5.1295","volume":"171","author":"WT Hughes","year":"1995","unstructured":"Hughes WT, LaFon SW, Scott JD, Masur H. Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia. J Infect Dis. 1995;171:1295\u2013301.","journal-title":"J Infect Dis"},{"key":"641_CR9","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1128\/JCM.03282-14","volume":"53","author":"F Robert-Gangneux","year":"2015","unstructured":"Robert-Gangneux F, Sterkers Y, Yera H, Accoceberry I, Menotti J, Cassaing S. et al. Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study. J Clin Microbiol. 2015;53:1677\u201384.","journal-title":"J Clin Microbiol"},{"key":"641_CR10","first-page":"1107","volume":"10","author":"C Katlama","year":"1996","unstructured":"Katlama C, Mouthon B, Gourdon D, Lapierre D, Rousseau F. Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expand Access Group Aids. 1996;10:1107\u201312.","journal-title":"Atovaquone Expand Access Group Aids"},{"key":"641_CR11","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/j.1399-3046.2007.00891.x","volume":"12","author":"O Megged","year":"2008","unstructured":"Megged O, Shalit I, Yaniv I, Stein J, Fisher S, Levy I. Breakthrough cerebral toxoplasmosis in a patient receiving atovaquone prophylaxis after a hematopoietic stem cell transplantation. Pedia Transpl. 2008;12:902\u20135.","journal-title":"Pedia Transpl"},{"key":"641_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1592\/phco.19.13.1050.31598","volume":"19","author":"J Falloon","year":"1999","unstructured":"Falloon J, Sargent S, Piscitelli SC, Bechtel C, LaFon SW, Sadler B. et al. Atovaquone suspension in HIV-infected volunteers: pharmacokinetics, pharmacodynamics, and TMP-SMX interaction study. Pharmacotherapy. 1999;19:1050\u20136.","journal-title":"Pharmacotherapy"},{"key":"641_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1399-3062.2008.00321.x","volume":"10","author":"A Tomonari","year":"2008","unstructured":"Tomonari A, Takahashi S, Ooi J, Tsukada N, Konuma T, Kato S. et al. No occurrence of Pneumocystis jiroveci (carinii) pneumonia in 120 adults undergoing myeloablative unrelated cord blood transplantation. Transpl Infect Dis. 2008;10:303\u20137.","journal-title":"Transpl Infect Dis"},{"key":"641_CR14","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cmi.2016.04.025","volume":"22","author":"A Conrad","year":"2016","unstructured":"Conrad A, Le Mar\u00e9chal M, Dupont D, Ducastelle-Lepr\u00eatre S, Balsat M, Labussi\u00e8re-Wallet H, et al. A matched case-control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication. Clin Microbiol Infect. 2016;22:636\u201341.","journal-title":"Clin Microbiol Infect"},{"key":"641_CR15","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/bmt.2010.285","volume":"46","author":"A Fontanet","year":"2011","unstructured":"Fontanet A, Chalandon Y, Roosnek E, Mohty B, Passweg JR. Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal. Bone Marrow Transpl. 2011;46:1272\u20133.","journal-title":"Bone Marrow Transpl"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0641-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0641-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0641-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:15:21Z","timestamp":1684617321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0641-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,21]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["641"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0641-y","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,21]]},"assertion":[{"value":"22 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}